Summary & Overview
CPT 33273: Reposition Subcutaneous Implantable Defibrillator Electrode
CPT code 33273 represents the surgical repositioning of a previously implanted subcutaneous implantable defibrillator electrode. This procedure is clinically important because proper electrode positioning is essential for accurate arrhythmia detection and effective defibrillation therapy; repositioning can address lead migration, suboptimal sensing, or changes in clinical status. Nationally, revisions of implantable defibrillator leads are a focus for both clinical outcomes and billing clarity due to device-related complications and hospital resource use.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and typical settings, plus a summary of benchmark considerations and payer coverage patterns where available. The publication outlines billing and coding context, common modifiers associated with device procedures, and points of attention for claims processing and reimbursement workflows.
The content provides a national perspective useful to clinicians, coding professionals, and policy analysts seeking to understand where CPT code 33273 fits within device management practice, typical sites of service, and payer coverage frameworks. Data not available in the input will be identified explicitly in relevant sections.
Billing Code Overview
CPT code 33273 describes the repositioning of a previously implanted subcutaneous implantable defibrillator electrode within the patient’s heart. This procedure involves surgically accessing and adjusting the position of an existing subcutaneous implantable cardioverter-defibrillator (S-ICD) electrode to restore or optimize sensing and therapeutic function.
-
Service type: Surgical revision of an implanted cardiac device lead
-
Typical site of service: Operating room or cardiac electrophysiology procedural suite
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55–75-year-old with a previously implanted subcutaneous implantable cardioverter-defibrillator (S-ICD) who presents with recurrent inappropriate shocks, lead migration, sensing issues, or inadequate sensing thresholds. The patient commonly reports new pocket pain or device displacement after trauma or weight change, or has device interrogation findings showing oversensing, undersensing, or high defibrillation thresholds. The clinical workflow includes device interrogation in clinic or hospital, chest radiography and/or fluoroscopy to assess lead position, preprocedural evaluation including anticoagulation review and infection screening, informed consent, and scheduling to the electrophysiology lab or operating room. The procedure involves surgical re-exploration of the device pocket and subcutaneous lead tunnel, repositioning the S-ICD electrode under fluoroscopic guidance, testing sensing and defibrillation thresholds, securing the lead and generator, and wound closure. Postprocedure care includes device reprogramming, wound checks, short-term antibiotic management if indicated, and follow-up device interrogation to confirm stable sensing and therapy delivery.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier or default | Not typically appended; used by some payors to indicate no modifier when required by format |